Drug Type Small molecule drug |
Synonyms OPM 3023 |
Target |
Action inhibitors |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Periodontitis | Phase 2 | Germany | - | - |
| Periodontitis | Phase 2 | - | - | |
| Periodontitis | Phase 2 | - | - | |
| Periodontitis | Phase 2 | - | - | |
| Rheumatoid Arthritis | Preclinical | Austria | - |





